These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1565467)

  • 1. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
    Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer.
    Woodruff KA; Rosenblatt JD; Moore TB; Medzoyan RH; Pai DS; Noland JL; Yamashiro JM; Wada RK
    Oncogene; 1995 Apr; 10(7):1335-41. PubMed ID: 7731684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
    Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
    Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
    Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of regulatory elements controlling human MYCN expression.
    Hiller S; Breit S; Wang ZQ; Wagner EF; Schwab M
    Oncogene; 1991 Jun; 6(6):969-77. PubMed ID: 2067849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
    Kim MK; Carroll WL
    Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide negatively regulates proliferation and promotes neuronal differentiation through N-Myc downregulation.
    Ciani E; Severi S; Contestabile A; Bartesaghi R; Contestabile A
    J Cell Sci; 2004 Sep; 117(Pt 20):4727-37. PubMed ID: 15331636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient replication of plasmids containing the SV40 origin in N-myc overexpressing human neuroblastoma cells.
    Lee NG; Yamaguchi J; Subramanian KN
    Oncogene; 1991 Jul; 6(7):1161-9. PubMed ID: 1650440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
    Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells.
    Ross RA; Hein AM; Braca JA; Spengler BA; Biedler JL; Scammell JG
    Oncol Res; 2002; 13(2):87-94. PubMed ID: 12392156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
    Amler LC; Schwab M
    Oncogene; 1992 Apr; 7(4):807-9. PubMed ID: 1565478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the human myeloperoxidase promoter region.
    Chumakov AM; Chumakova EA; Chih D; Koeffler HP
    Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1.
    Judware R; Culp LA
    Oncogene; 1997 Mar; 14(11):1341-50. PubMed ID: 9178894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.